1275 related articles for article (PubMed ID: 35094873)
1. Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges.
Wang C; Wu W; Yang H; Ye Z; Zhao Y; Liu J; Mu L
Trends Genet; 2022 May; 38(5):468-482. PubMed ID: 35094873
[TBL] [Abstract][Full Text] [Related]
2. Causes and Consequences of Polycystic Ovary Syndrome: Insights From Mendelian Randomization.
Zhu T; Goodarzi MO
J Clin Endocrinol Metab; 2022 Feb; 107(3):e899-e911. PubMed ID: 34669940
[TBL] [Abstract][Full Text] [Related]
3. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
[TBL] [Abstract][Full Text] [Related]
4. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
[TBL] [Abstract][Full Text] [Related]
5. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
Jiang X; Deng Q; Stener-Victorin E
Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
[TBL] [Abstract][Full Text] [Related]
7. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
[TBL] [Abstract][Full Text] [Related]
8. Polycystic Ovary Syndrome and Risk of Five Common Psychiatric Disorders Among European Women: A Two-Sample Mendelian Randomization Study.
Jin L; Yu J; Chen Y; Pang H; Sheng J; Huang H
Front Genet; 2021; 12():689897. PubMed ID: 34211505
[No Abstract] [Full Text] [Related]
9. Polycystic Ovary Syndrome and Risk of Type 2 Diabetes, Coronary Heart Disease, and Stroke.
Zhu T; Cui J; Goodarzi MO
Diabetes; 2021 Feb; 70(2):627-637. PubMed ID: 33158931
[TBL] [Abstract][Full Text] [Related]
10. Sex hormone-binding globulin genetic variation: associations with type 2 diabetes mellitus and polycystic ovary syndrome.
Chen C; Smothers J; Lange A; Nestler JE; Strauss Iii JF; Wickham Iii EP
Minerva Endocrinol; 2010 Dec; 35(4):271-80. PubMed ID: 21178921
[TBL] [Abstract][Full Text] [Related]
11. Maternal Polycystic Ovary Syndrome and Offspring Birth Weight: A Mendelian Randomization Study.
Gan Y; Lu D; Yan C; Zhang J; Zhao J
J Clin Endocrinol Metab; 2022 Mar; 107(4):1020-1029. PubMed ID: 34849988
[TBL] [Abstract][Full Text] [Related]
12. No causal association between anti-Mullerian hormone (AMH) levels and polycystic ovary syndrome (PCOS)-a Mendelian randomization analysis.
Deshmukh H; Sathyapalan T
Endocrine; 2023 Aug; 81(2):388-389. PubMed ID: 37115376
[No Abstract] [Full Text] [Related]
13. Polycystic Ovary Syndrome Susceptibility Loci Inform Disease Etiological Heterogeneity.
Zhang Y; Movva VC; Williams MS; Lee MTM
J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207127
[TBL] [Abstract][Full Text] [Related]
14. Causal pathways linking polycystic ovary syndrome to distinct breast cancer subtypes through mediator factors: a multivariable mendelian randomization analysis.
Cao R; Chen L; Liu Y; Wang X; Ma R; Zhao Q; Du Y
J Ovarian Res; 2023 Nov; 16(1):215. PubMed ID: 37957709
[TBL] [Abstract][Full Text] [Related]
15. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
16. The relationships of sex hormone-binding globulin, total testosterone, androstenedione and free testosterone with metabolic and reproductive features of polycystic ovary syndrome.
Simons PIHG; Valkenburg O; Bons JAP; Stehouwer CDA; Brouwers MCGJ
Endocrinol Diabetes Metab; 2021 Jul; 4(3):e00267. PubMed ID: 34277990
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.
Wickham EP; Ewens KG; Legro RS; Dunaif A; Nestler JE; Strauss JF
J Clin Endocrinol Metab; 2011 Apr; 96(4):E719-27. PubMed ID: 21252242
[TBL] [Abstract][Full Text] [Related]
19. No association effect of genetic polymorphism was observed between polycystic ovary syndrome and cardiovascular diseases risk: a mendelian randomization study.
Zhang X; Huangfu Z; Wang S
Endocrine; 2023 Dec; 82(3):695-706. PubMed ID: 37668928
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
